NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/10/2024
Back to search
Official data from USPTO
KANION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/10/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
07/29/2003
Registration date
03/01/2005
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/10/2024
Last transaction
08/10/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/25/2000
First use in commerce
08/12/2000
Drawing code
3
Owner type
16
Owner location
Jiangsu, CN
Examiner
CHICOSKI, JENNIFER D
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two Chinese characters and KANION.
Holders and representatives
Holders
Jiangsu Kanion Pharmaceutical Co., Ltd.
Representatives
Prakash NAMA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for the treatment of gynecological diseasesobstetric diseasesbleeding after induced abortionabdominal pain after insertion of intrauterine contraceptive devicemammary diseasesdiseases of the urogenital tractspondylitisosteoarthritisarthritispainful heelosteoarthrosis deformans endemicahemicraniacluster headachetensional headachehyperlipemiablood hyperviscositybrain trauma syndromevertigoatherosclerosispremonitory apoplexyischemic apoplexy and its sequelagastrointestinal diseasedeficiency of kidney-yinlumbagopainful legsneurastheniacardiovascular diseasescerebrovascular diseasesmenopause syndromeexcessive blood lipidirregular flow of Qihypochondriac paindysmenorrhealinfluenzainflammation of the upper respiratory tractpharyngitispneumonia and epidemic parotitiswind-cold headachepain in the supra-orbital bonedistention and pain due to nasal sinusitiswind-damp headache and nervous headache; Chinese medicines for the treatment of gynecological diseasesobstetric diseasesbleeding after induced abortionabdominal pain after insertion of intrauterine contraceptive devicemammary diseasesdiseases of the urogenital tractspondylitisosteoarthritisarthritispainful heelosteoarthrosis deformans endemicahemicraniacluster headachetensional headachehyperlipemiablood hyperviscositybrain trauma syndromevertigoatherosclerosispremonitory apoplexyischemic apoplexy and its sequelagastrointestinal diseasedeficiency of kidney-yinlumbagopainful legsneurastheniacardiovascular diseasescerebrovascular diseasesmenopause syndromeexcessive blood lipidirregular flow of Qihypochondriac paindysmenorrhealinfluenzainflammation of the upper respiratory tractpharyngitispneumonia and epidemic parotitiswind-cold headachepain in the supra-orbital bonedistention and pain due to nasal sinusitiswind-damp headache and nervous headache; nutritional supplements; baby food; medicinal preparations in liquid form for dissolving cholesterolmedicinal preparations in liquid form for softening and expanding blood vesselsmedicinal preparations in liquid form for removing blood lipidmedicinal preparations in liquid form for the treatment of hypertensionhyperlipemiasenile dementiacoronary heart diseaseatherosclerosishyperlipemia; ginseng for medicinal use; medicinal tea for weight-loss; herbal teas for medicinal purposes; dietary supplement tablets for the use of anti-fatigueprotecting the liver against chemical lesionimproving the blood circulationsmoothing the skinrefreshing the mindinvigorating vital energypromoting metabolismimproving immunity and regulating bilaterally the functional balance of human body; food supplements; nutritional supplements; nutritionally fortified beverages; and surgical dressings
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/10/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/30/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
05/09/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2018
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/09/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/09/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/09/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2014
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
04/28/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
04/28/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/28/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/22/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/18/2010
ES8R
TEAS SECTION 8 RECEIVED
10/14/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/25/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/25/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/02/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/02/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2005
PUBO
PUBLISHED FOR OPPOSITION
12/07/2004
NPUB
NOTICE OF PUBLICATION
11/17/2004
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/30/2004
ALIE
ASSIGNED TO LIE
09/13/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2004
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/27/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2004
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2004
CNRT
NON-FINAL ACTION MAILED
02/12/2004
DOCK
ASSIGNED TO EXAMINER
02/09/2004
Continuous trademark protection
Get notified about every new filing that threatens KANION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.